BIOMAT Database Logo BIOMAT Database Logo

Production of the antibiotic D-4-amino-3-isoxazolidone by bacteria. 1968

E O Stapley, and T W Miller, and M Jackson

UI MeSH Term Description Entries
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D011549 Pseudomonas A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants. Chryseomonas,Pseudomona,Flavimonas
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

E O Stapley, and T W Miller, and M Jackson
An antibiotic produced by streptomyces strain No. 2608, identical with D-4-amino-3-isoxazolidone.
July 1970, Acta medica et biologica,
E O Stapley, and T W Miller, and M Jackson
The antimicrobial evaluation of oxamycin (D-4-amino-3-isoxazolidone), a new broad-spectrum antibiotic.
April 1955, Antibiotics & chemotherapy (Northfield, Ill.),
E O Stapley, and T W Miller, and M Jackson
[Cycloserine, oxamycin, PA 94, three names for an antibiotic drug, D-4-amino-3-isoxazolidone].
January 1956, Il Farmaco; edizione scientifica,
E O Stapley, and T W Miller, and M Jackson
SYNERGISM OF D-4-AMINO-3-ISOXAZOLIDONE AND O-CARBAMYL-D-SERINE.
January 1964, The Journal of antibiotics,
E O Stapley, and T W Miller, and M Jackson
Excretion and metabolism of D-4-amino-3-isoxazolidone (cycloserine) by the Rhesus monkey.
August 1955, Antibiotics & chemotherapy (Northfield, Ill.),
E O Stapley, and T W Miller, and M Jackson
On neuropsychic disorders due to D-4-amino-3-isoxazolidone (cycloserine).
January 1957, L'Ospedale psichiatrico,
E O Stapley, and T W Miller, and M Jackson
[Antibacterial activity of various D-4-amino-4-isoxazolidone analogs].
April 1957, Bollettino della Societa italiana di biologia sperimentale,
E O Stapley, and T W Miller, and M Jackson
Discovery, development, and antimicrobial properties of D-4-amino-3-isoxazolidone (oxamycin), a new antibiotic produced by Streptomyces garyphalus n. sp.
April 1955, Antibiotics & chemotherapy (Northfield, Ill.),
E O Stapley, and T W Miller, and M Jackson
5-Carboxamido-4-amino-3-isoxazolidone, and asparagine analogue.
July 1978, Journal of medicinal chemistry,
E O Stapley, and T W Miller, and M Jackson
Study on orientomycin, identified with d-4-amino-3-isoxazolidone. Studies on actinomyces antibiotics. XXXVII.
July 1956, The Journal of antibiotics,
Copied contents to your clipboard!